Log in to save to my catalogue

The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglycerid...

The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglycerid...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7099020

The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis

About this item

Full title

The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis

Publisher

England: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2020-03, Vol.5 (1), p.23

Language

English

Formats

Publication information

Publisher

England: Nature Publishing Group UK

More information

Scope and Contents

Contents

Dyslipidemia exhibits a high incidence after liver transplantation, in which tacrolimus, a widely used immunosuppressant, plays a fundamental role. MicroRNAs and related circRNAs represent a class of noncoding RNAs that have been recognized as important regulators of genes associated with lipid metabolism. However, their transcriptional activities...

Alternative Titles

Full title

The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7099020

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7099020

Other Identifiers

ISSN

2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-020-0105-2

How to access this item